Australia Lipid Market Size & Outlook, 2022-2030
Australia lipid market, 2018-2030 (US$M)
Related Markets
Australia lipid market highlights
- The Australia lipid market generated a revenue of USD 458.8 million in 2022 and is expected to reach USD 786.2 million by 2030.
- The Australia market is expected to grow at a CAGR of 7% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 458.8 million |
| Market revenue in 2030 | USD 786.2 million |
| Growth rate | 7% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, Australia accounted for 4.9% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China lipid market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 989.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.44% in 2022. Horizon Databook has segmented the Australia lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Nutraceutical products have consistently been in demand after the outbreak of COVID-19 in Australia. Australians are motivated toward regularly consuming food beneficial to health. Nutraceutical products include dietary supplements that contain both nutritional and therapeutic functions.
Nutraceutical products include functional beverages, functional foods, and dietary supplements. The COVID-19 pandemic has increased awareness regarding the benefits of functional food among Australians, which is expected to positively influence the demand for lipids in Australia over the coming years.
The Australian nutraceuticals industry is considered to have a positive outlook in the coming years. In June 2022, Australia-based nutraceutical company, Star Combo Pharma revealed its plans to invest USD 7.5 million toward the development of a new production facility for nutraceutical products in order to double its production capacity.
Reasons to subscribe to Australia lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia lipid market , including forecasts for subscribers. This country databook contains high-level insights into Australia lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia lipid market size, by phase, 2018-2030 (US$M)
Australia Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
